ArticleJAC-antimicrobial resistance2025
Evaluating the impact of a 10 year reduction in critically important antibiotic use on the occurrence of antibiotic resistance in
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Incorporating Sales Value into Weight-Based Veterinary Antimicrobial Use Surveillance: An Analysis of Veterinary Antimicrobial Sales Data in Japan, 2011-2024.Antibiotics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: In France, a 10 year national policy to reduce antibiotic use (ABU) in animals led, respectively, to an 88% and 94% decrease in animal exposure to fluoroquinolones and third- and fourth-generation cephalosporins (3GC-4GC) between 2011 and 2021. Methods: Building on national surveillance data, this study evaluated the impact of this national policy on reducing the occurrence of resistance to fluoroquinolones and 3GC-4GC in clinical Results: Statistical analysis of available ABU and ABR surveillance data demonstrated a significant and sustainable impact on the occurrence of resistance to fluoroquinolones in clinical Conclusions: The French 10 year national policy had a successful impact on the occurrence of resistance to fluoroquinolones and 3GC-4GC in clinical
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.